Pantherna Therapeutics
Pre-clinicalWe develop advanced lipid nanoparticles (LNP) technologies for non-hepatic, organ- and cell-selective delivery of mRNA-based therapeutics.
Founded
2015
Focus
RNA & Gene Therapy
About
We develop advanced lipid nanoparticles (LNP) technologies for non-hepatic, organ- and cell-selective delivery of mRNA-based therapeutics.
Funding History
2Total raised: $28.5M
Series A$25MAndera PartnersJun 15, 2021
Seed$3.5MHigh-Tech GründerfondsJun 15, 2019
Company Info
TypePrivate
Founded2015
LocationHalle, Germany
StagePre-clinical
Contact
SIMILAR COMPANIES
300Microns
Pre-clinical · Munich
BetaSense
Pre-clinical · Berlin
AB Diagnostic Systems
Pre-clinical · Jena
bbi-biotech
Pre-clinical · Berlin
Mireca Medicines
Pre-clinical · Munich
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile